The global economy remained resilient in CY 2025, expanding by 3.4% supported by steady private consumption, continued strengthening of the services sector a strong investment in technology-led domain. However, this growth faced a complex mix of challenges, including heightened geopolitical tensions and trade policies increasingly driven by political and security considerations rather than efficiency or multilateral agreements.
Advanced economies recorded a growth of 1.9% while emerging market and developing economies (EMDEs) grew at a stronger rate of 4.4%, underscoring relatively robust demand conditions in developing regions. At the same time, global trade dynamics continued to be shaped by lingering frictions and supply chain realignments. Geopolitical conflicts further disrupted commodity markets, particularly rising energy prices and creating supply chain bottlenecks, influencing global cost structures.
Overall, the global economy transitioned from a phase of steady, technology-supported growth to an environment defined by heightened and geopolitical uncertainty, supply-side disruptions and renewed inflationary pressures.
The global economic outlook has moderated amid geopolitical developments, with growth expected to slow under elevated uncertainty and supply side disruptions. According to the IMFs reference forecast, global GDP growth is projected to expand at 3.1% in CY 2026, reflecting a downward revision of 0.2% points compared to earlier estimates.
Global headline inflation, which stood at approximately 4.2% in CY 2025, is expected to rise further due to higher energy prices, supply chain disruptions and secondary effect on wages and costs.
World Economic Outlook Growth Projections (Real GDP, annual percent change)
| CY 2025 | CY 2026 (P) | CY 2027 (P) | |
| Global Economy | 3.4 | 3.1 | 3.2 |
| Advanced Economies | 1.9 | 1.8 | 1.7 |
| Emerging Market and Developing Economies | 4.4 | 3.9 | 4.2 |
P-Projection Source-IMF, World Economic Outlook, April 2026
The Indian economy remained resilient during FY 2025-26, supported by robust macroeconomic fundamentals, continued policy support and broad-based sectoral performance. As per the Second Advance Estimates, real GDP growth of the year was 7.7% higher than 7.1% in FY 2024-25, reflecting sustained economic momentum. Growth was underpinned by strong domestic demand, with private consumption and investment remaining key drivers, supported by favourable financial conditions and continue infrastructure spending. The services sector continued to lead growth, while manufacturing recorded strong expansion indicating improving industrial activity and capacity utilisation.
Inflation moderated during the year, with CPI inflation easing to - 3.4% by March 2026, aided by softening food prices and improved supply-side conditions. Monetary policy remained supportive, with the policy repo rate maintained at 5.25% while liquidity conditions remained adequate to support economic activity. Indias external position remained stable supported by resilient services exports, steady remittance inflows and adequate foreign exchange reserves of around USD 700 billion, providing a buffer against global uncertainties.
The labour market remained stable, with the labour force participation rate broadly steady at 55.9% in January 2026, indicating resilience despite seasonal fluctuations. High-frequency indicators pointed towards sustained economic activity, supported by growth in GST collection, credit expansion and consumption trends. Additionally, Indias economic trajectory was supported by structural reforms, improved digital infrastructure and enhanced manufacturing capabilities, strengthening its position as one of the fastest-growing major economies globally.
The agriculture and allied sector continued to play a stabilising role, contributing to around 18% of total GVA and registering steady growth. The sectors performance was supported by improving crop output and a continued increase in food grain production, alongside favourable reservoir levels. Sustained policy support and stable agricultural activity also contributed to strengthening rural demand, providing a balanced underpinning to overall economic growth.
Overall, despite global headwinds such as geopolitical tensions, supply chain disruptions and commodity price volatility, the Indian economy maintained a strong growth trajectory, supported by resilient domestic demand, policy interventions and improving macroeconomic stability.
The Indian economy is expected to maintain steady growth in FY 2026-27, with real GDP projected at 6.6% reflecting resilience amid global uncertainties. Domestic demand is anticipated to remain a key growth driver, supported by stable consumption trends and continued infrastructure-led capital expenditure. Policy initiatives, including focus on manufacturing expansion as well as digital transformation and strengthening supply chains are expected to support investment momentum and enhance productivity across sectors.
Inflation is expected to remain moderate, around - 4.5% - 4.6% supported by stable food price, easing supply-side pressures and effective policy measures.
On the policy front, the Union Budget FY 2026-27 continues to prioritising agriculture and rural development, with an allocation of ? 1.32 lakh crore towards agriculture and allied sectors and ? 1.70 lakh crore towards fertiliser subsidies, aimed at enhancing farm productivity and supporting rural incomes. While global headwinds such as supply chain disruptions and trade uncertainties may impact external demand, strong macroeconomic fundamentals and ongoing structural reforms are expected to support Indias growth trajectory.
Indian GDP Growth Trend (%)
| FY 2024-25 | FY 2025-26 | FY 2026-27 (P) |
| 7.1 | 7.7 | 6.6 |
The global agrochemicals market size was estimated at USD 299.7 billion in 2025 and is projected to reach USD 449.9 billion by 2033, growing at 5.2% CAGR from 2026 to 2033. The growth is primarily driven by increasing demand for high-yield and quality crop production across key agricultural sectors, where efficient pest control, soil fertility and crop protection are critical. Regionally, Asia Pacific held the largest revenue share in the global agrochemicals industry, accounting for 52.7% in 2025. The fertilisers segment dominated the market by product category, accounting for a significant 77.1% share of total revenue in 2025. In terms of application, cereals and grains emerged as the leading category, contributing 46.8% to overall market revenue during the year.
Agrochemicals Market (Market Size USD Billion)
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
| 299.7 | 315.3 | 449.9 |
Legend: Fertilizers, Crop Protection Chemicals, Plant Growth Regulators, Other Products Source: Grandview Research Report
Indias agrochemical industry has demonstrated steady growth, with the market reaching approximately USD 16.1 billion in 2025 and is projected to grow to USD 23.6 billion by 2034, registering a CAGR of 4.19% during 2026-34. This growth is driven by increasing advancements in agricultural technologies, including precision farming and the development of more effective agrochemical formulations, which are supporting improved crop productivity.
From a segmentation perspective, the market comprises key product categories such as fertilisers, pesticides, adjuvants and other crops, with demand driven by crop-specific requirements and cultivation patterns. This segmentation highlights the industrys dependence on both crop mix and input intensity, with consumption patterns evolving in line with agricultural practices and productivity needs.
India Agrochemicals Market Forecast - Size, By Type, 2025-2034 (USD Billion)
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
| 16.1 | 23.6 |
Legend: Fertilizers, Pesticides, Adjuvants, Plant Growth Regulators Source: Imarc Report
The Indian agrochemical industry continues to witness structurally strong demand, underpinned by improving agricultural fundamentals, rising cropping intensity and a gradual shift towards yield optimisation. The cultivated area increased to approximately 29.5 million hectares in FY25 (PY: 29.1 million hectares), while foodgrain production rose to around 369 million tonnes (PY: 355 million tonnes), reflecting higher agricultural activity and a growing need for crop protection inputs. In addition, expansion in distribution networks, with pesticide sale points exceeding 3 lakhs by FY25, has improved last-mile accessibility and supported deeper market penetration. On the external front, export volumes reached nearly 0.7 million tonnes in FY25 and stabilised in FY26, supported by steady demand across key markets such as the United States and parts of Europe and Latin America.
Raw material prices for key agrochemical inputs have largely stabilised following the correction observed over the past two years. This has improved cost visibility for manufacturers, enabling better production planning, inventory management and procurement strategies. While stable input costs support operational efficiency and margin management, they also increase competitive intensity, particularly in commoditised segments where pricing differentiation remains limited. As a result, industry growth is increasingly driven by volume expansion, with companies focusing on cost optimisation and product mix improvements to sustain profitability.
The industry has witnessed a recovery following the correction in FY24, with performance improving in FY25, driven by volume growth and the normalisation of channel inventories. The total operating income of leading agrochemical companies grew by approximately 9% year-on-year in FY25, supported by stabilising demand across key export markets.
Operating performance also strengthened, aided by lower raw material costs, improved capacity utilisation, better product mix, contributing to recovery in operating margins. This trend has continued into FY26, indicating a transition towards a more stable, volume-led growth phase for the industry.
Variability in weather patterns, including irregular monsoons and rising temperatures, along with evolving pest dynamics, is increasing crop vulnerability. Farmers are encountering frequent infestations from resistant insect and fungal strains, leading to a structural increase in demand for advanced and combination agrochemical formulations.
The shift towards climate-resilient agricultural practices is further accelerating a the adoption of specialty herbicides, fungicides and Integrated Pest Management (IPM) solutions.
Additionally, rising pest resistance is driving the use of newer molecule blends and precision application techniques enhancing effectiveness while minimising input wastage.
Indias API industry, with a market size of USD 15-16 billion, is entering a period of steady expansion. Over the next two years, growth of 5-7% is expected, supported by factors such as an ageing population, wider healthcare access, rising insurance penetration and the increasing prevalence of chronic diseases. The industry is also being shaped by opportunities resulting from the loss of exclusivity on several drugs and by expansion into emerging markets.
Concurrently, a pipeline of high-potent and complex APIs is under development, with commercialisation expected over the medium term, pointing to Indias gradual move up the value chain. Technology adoption and modern manufacturing practices are beginning to play a role as well, setting the stage for how competitiveness and efficiency will evolve across the sector.
[The text continues: 2026-2030, outpacing the broader industry growth of 7-8% driven by increasing demand for targeted and speciality therapies.]
Growth Drivers for Indian API industry
| Current Market Size | Favourable government policies | HPAPI | Domestic market growth | Export growth from market expansion | Market size |
| USD 15-16 bn | 2% | 1% | 2% | 1% | USD 16-17 bn |
Source: Care Edge Ratings Report
India imports 30-35% of its API requirements, of which Chinese imports account for 70%. Chinas dominance in global markets stems for decades of cost-efficient bulk manufacturing, favourable policies and the availability of resources at low cost, reinforced by aggressive cost rationalisation strategies.
Indias Bulk drug and drug intermediaries import - Country wise (Value) FY25
| Country | Share |
| China | 74% |
| Italy | 3% |
| Singapore | 2% |
| USA | 2% |
| Spain | 2% |
| Germany | 2% |
| Others | 15% |
Source: Care Edge Ratings Report
Indias heavy reliance on imported bulk drugs and drug intermediaries has emerged as a critical vulnerability in the pharmaceutical supply chain, particularly in the context of global supply disruptions and geopolitical uncertainties. To counter this growing dependence, the government introduced the Production-Linked Incentive (PLI) scheme in 2020 to promote the domestic manufacture of bulk drugs. While the full impact of these measures will take time to materialise, progress is visible, with 30 projects already completed, indicating gradual capacity build-up.
In Q3 FY26, the government introduced a Minimum Import Price (MIP) for key pharmaceutical ingredients as an anti-dumping measure. Complementing the PLI scheme, the MIP aims protect domestic manufacturers from price undercutting, improving capacity utilisation and supporting the development of a more resilient a competitive API ecosystem.
The global Active Pharmaceutical Ingredients (API) market is estimated at approximately USD 200-250 billion in 2025, with high-potent APIs (HPAPIs) accounting for around 12-15% of the total market. The high
A key growth opportunity for the Indian pharmaceutical sector lies in complex generics and high-potent APIs, which are designed to deliver strong therapeutic effects at low dosages and become increasingly integral to advanced treatment protocols. Demand is largely driven by targeted therapies, particularly in oncology, which accounts for nearly 75% of usage, along with hormonal and other specialised applications.
These products typically offer higher margins and are characterised by significant entry barriers arising from complex development and manufacturing processes, stringent containment requirements and specialised manufacturing capabilities, resulting in relatively limited competition. Additionally, high switching costs and regulatory stringency provide greater pricing resilience compared to commoditised API segments.
Indian manufacturers are well positioned to capitalise on this opportunity, supported by their strong technical expertise, a skilled workforce, established customer relationships and robust manufacturing infrastructure. Increasing investments in high-containment facilities, R&D capabilities and regulatory compliance are enabling a gradual shift towards higher-value, technology-intensive segments, strengthening Indias role in the global pharmaceutical value chain.
India Pesticides Limited (IPL), incorporated in 1984, is an R&D-driven agrochemical company engaged in the manufacturing of agrochemical technical, formulations and active pharmaceutical ingredients (APIs). Over the years, the Company has established itself as a reliable partner for both domestic and international customers, supported by its ability to develop client-specific molecules efficiently and deliver cost-effective solutions. IPLs operating model is anchored in process optimisation, backward integration and product differentiation, which not only enhances cost competitiveness but also provides greater control over input volatility and supply chain dependencies, particularly in a price-sensitive and cyclical industry environment in both domestic and export markets.
The Companys manufacturing footprint is strategically located across Lucknow and Hardoi (Uttar Pradesh), with integrated facilities supporting technical and formulation production. This integrated manufacturing base enables operational synergies and strengthens supply reliability for customers. IPL continues to strengthen its operational capabilities through capacity expansion, process improvements and backward integration initiatives, enhancing supply reliability and cost efficiencies. Its R&D-driven approach, supported by two DSIR-recognised in-house laboratories, enables continuous development of new molecules and improvement in product quality, positioning the Company to cater to evolving industry requirements.
IPL has built a diversified product portfolio comprising a wide range of technical, formulations and APIs, with a strong presence in both domestic and international markets. The Company exports to 35+ countries, with key markets including Europe and Australia and maintain long-standing relationships with global customers.
Key Highlights:
SSL (U24290UP2021PLC140490) is the wholly-owned subsidiary of IPL that was incorporated on January 18, 2021. Its manufacturing facility is located at UPSIDAs Sumerpur Industrial Area, Dist. Hamipur, Uttar Pradesh. The Company commissioned a new Formulation Plant, a commercial Technical Block, and a modern Pilot Plant to support future product scale-up and development. The Multipurpose Process Plant for technical fungicides and insecticides is ready for commissioning in May 2026. The Company has also initiated the development of a Greenfield Herbicide Block and an additional Fungicide Block, expected to be commissioned during FY 2026-27. These initiatives, coupled with ongoing product registrations and infrastructure enhancement, are expected to accelerate new product launches. As on March 31, 2026, the Company had obtained 50 registrations for indigenous and export manufacturing.
Amona (U20210UP2024PTC195286) is a subsidiary of IPL, which focuses on importing & exporting and registration of agro-chemicals, biological products. It has its Registered Office situated at 7-Way Lane, Corporation no. 27/12 Hazratganj, Gokhley Marg, Lucknow, 226001 and its Corporate Office at Waterworks Road, Swarup Cold Storage, Aishbagh, Lucknow, 226004.
The Company has reaffirmed Long Term/Short Term Bank Facilities CARE A+ and Short-Term Bank Facilities CARE A1+ from Care ratings. This rating can be attributed to the Companys efficient operations.
The Company reported revenue of 1057.11 crore in FY 2026.
In FY 2026, the combined revenue from Technical Products and Active Pharmaceutical Ingredients (APIs) accounted for 71% of the Companys total revenue, generating a total of 746 crore.
Key Agrochemical Technical produced by IPL include:
| Key Technicals | Category | Application |
| Prosulfocarb | Herbicide | Used for wheat control in wheat and potato cultivation |
| Pretilachlor | Herbicide | Applied for weed management in rice cultivation |
| Flufenacet | Herbicide | Used in maize, wheat, potato and soybean crops |
| Cymoxanil | Fungicide | Controls downy mildew in grapes, potatoes and vegetables |
| Captan | Fungicide | Used for protection of fruits, vegetables and ornamental plants |
| Folpet | Fungicide | Controls fungal diseases in vineyards and cereal crops |
| Ziram | Fungicide | Used for protection of apples, almonds, peaches and pears |
| Dodine | Fungicide | Primarily used in apple and pear cultivation |
| Thiophanate Methyl | Fungicide | Used for fungal disease control in fruit and vegetable crops |
| Thiram | Fungicide | Used as a seed treatment fungicide across multiple crops |
| Diafenthiuron | Insecticide | Applied in cotton crop protection |
| PEDA | Intermediate | Intermediate used in the manufacturing of Pretilachlor |
| Phalamide | Intermediate | Intermediate used in agrochemical manufacturing |
| Tetra Hydro Phalamide | Intermediate | Intermediate used in agrochemical production processes |
| Pyriproxyfen | Insecticides | Used in field crops |
The Formulation business of the Company generated revenue ? 311 crore in FY 2025-26
Few Branded Formulations:
| Category | Brands |
| Herbicide | Grip, Pendizet, Trisol, Clogold, Midash, Safer, Eliminator, Penda, Aatish, Agni, Gajab, Agni Plus, Permiza, Trisol WG, Agni EW, Blue |
| Fungicides | Dollar, Vardhan, Vecto, Trim, Sodhit, Captax-50, Natraj, Sanjeevani, Talwar, Trim WG, Prop, Thalonil, Mox, Ziram-27, Ziram-80, Takatwar, Solid, Tab, Vallet, Super-Strike, Fixer. |
| Insecticides | Carbo, Amida, Frem, Byprten, Immidator, Tridev, Difen, Frame, Soldier, Crotax, Tez, 505, A-One Sc. Nexxa TC, Support, Super Raider, Super Pratap, Impart, Warrior SC, Tara, Josh, Tara FS, Drona, Dhoom, Immidex, Virat, Astron, IPL Drona, Extra Support, Secure, Super Pratap SP |
| Acaricide | Guru SP, Guru, Shakti, Contanol - EC, Star, Talvar, Namaskar |
| Growth Regulators | Chakra, Guru SP, Guru, Contanol - EC |
The Company manufacture and supply a wide range of formulations, including insecticides, Fungicides, Herbicide, growth regulators and acaricides. They also offer a ready to use product range that delivers branded solutions to customers through their distribution partners.
India Pesticides Limited has strengthened its position in international markets through its diversified product portfolio, customised offerings and consistent focus on quality. The Company exports its products to more than 35 countries across regulated markets including the United States, Europe, Australia, Africa, South America and Asia, reflecting its expanding global presence and long-standing customer relationships.
During FY 2025-26, the Company continued to enhance its global footprint through new product registrations in Serbia and Australia, increasing its total worldwide registrations to 53. With dedicated business development teams operating in Europe and the United States, IPL remains focused on broadening its market reach, strengthening channel partnerships, and identifying new growth opportunities across international markets. This strategic focus reinforces the Companys long-term commitment to expanding its export business and diversifying its geographical presence.
The Company also offers Custom Synthesis and Contract Manufacturing services for various active ingredients and intermediates. Its in-house R&D, project execution and manufacturing capabilities enable the development of products tailored to customer requirements, while maintaining focus on sustainability standards, process efficiency and product quality.
( ? in Crores)
| Particulars | FY 2025-26 | FY 2024-25 | Change (%) |
| Revenue from operations (Net) | 1057 | 829 | 28% |
| Other income | 21 | 15 | 40% |
| Cost of materials consumed | 614 | 474 | 30% |
| Power and fuel | 42 | 35 | 20% |
| Freight, handling and packing | 23 | 20 | 15% |
| Employee benefits expenses | 63 | 53 | 19% |
| Depreciation and amortisation expenses | 21 | 18 | 17% |
| Finance cost | 7 | 4 | 75% |
| EBITDA | 197 | 136 | 45% |
| Profit after tax | 122 | 84 | 45% |
The total income of the Company was ? 844.02 crores in FY2024-25 and ? 1078.35 crores in FY 2025-26. This comprises revenue from operations and other income. Revenue from operations is ? 829.02 crores in FY 2024-25 and ? 1057.11 crores in FY 2025-26.
( ? in Crores)
| Particulars | FY 2025-26 | FY 2024-25 | Change (%) |
| Financial liabilities | |||
| I. Borrowings | 70 | 49 | 43% |
| II. Lease liabilities | 2 | 2 | - |
| III. Trade payables | 136 | 118 | 15% |
| IV. Other financial liabilities | 24 | 21 | 14% |
| Other current liabilities | 18 | 18 | - |
| Provisions | 6 | 6 | - |
| Current tax liabilities | 0 | 1 | - |
| Total current liabilities | 256 | 215 | - |
| Working Capital (Net Current Assets) | 579 | 509 | 14% |
Inventory: Inventory increased by 17% from 242 crores as on March 31, 2025 to 284 crores as on March 31, 2026. The inventory turnover ratio was at 3.80 vis- à -vis 3.69 in the previous year. Higher inventory level was an account of increased production volumes, stocking of raw materials and finished goods to support higher sales growth, capacity expansion initiatives, and ensuring uninterrupted supply to domestic and export markets.
Trade receivables: Increased by 5% compared to the previous year. An increase in debtors was mainly on account of higher sales during the year, particularly in the last quarter, coupled with extended credit period granted to certain customers in line with normal business practices.
Trade payables: Creditors increased from by 5% during the year owing to higher level of purchase.
Net cash flows: Net cash flow from operating activities increased significantly to 67.83 crore during the year under review as against 1.60 crore in the previous year, mainly due to improved operating profitability, better working capital management and higher cash generation from core business operations.
( ? in Crores)
| Particulars | FY 2025-26 | FY 2024-25 | Change (%) |
| Equity | |||
| Equity Share Capital | 11.52 | 11.52 | - |
| Other equity | 1005.99 | 891.92 | 12.97% |
| Total Equity | 1017.51 | 903.44 | 12.63% |
| Financial Liabilities | |||
| I. Non-current Borrowings | 4.05 | 2.33 | 73.82% |
| II. Current Borrowings | 69.95 | 49.29 | 41.92% |
| Total Debt (B) | 74 | 51.62 | 43.36% |
| Deferred Tax Liabilities (Net) (C) | 25.08 | 16.72 | 50.00% |
| Total Capital Employed | 1116.59 | 971.78 | 14.90% |
As per the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations 2018 states that the Company is required to provide details of significant changes (i.e. change of 25% or more as compared to the immediately previous financial year) in key financial ratios, along with detailed explanation therefore.
Key financial ratios of the Company are as below:
| Particulars | FY 2025-26 | FY 2024-25 | % Variance | Reason for Variance greater than 25% |
| Current Ratio | 3.21 | 3.36 | (4.46%) | NA |
| Debt - Equity Ratio | 0.07 | 0.06 | 16.67% | NA |
| Debt Service Coverage Ratio | 29.37 | 21.79 | 35.00% | Improved earnings available for debt services |
| Return on Equity | 12.73 | 9.75 | 30.56% | Increase is on account of increased profit as compared to previous year mainly driver by higher margin & revenue. |
| Inventory Turnover Ratio | 3.80 | 3.69 | 3.00% | NA |
| Trade receivables Turnover Ratio | 3.02 | 2.84 | 5.00% | NA |
| Trade Payables turnover Ratio | 4.56 | 4.66 | 4.08% | NA |
| Net profit ratio | 11.61 | 10.18 | 14.05% | NA |
| Net capital turnover ratio (in times) | 1.82 | 1.63 | 12.00% | NA |
| Return on capital employed (%) | 15.77 | 12.14 | 30.00% | Increase due to higher profitability during the year. |
| Return on investment (ROI) (%) | 12.02 | 9.34 | 29.00% | Increase due to higher profitability during the year. |
India Pesticides Limited recognises that its workforce is integral to its sustained growth and operational performance. The Company focuses on attracting, developing and retaining skilled talent while building a supportive, performance-driven and accountable work environment. It places emphasis on continuous learning and professional development through structured training and development initiatives, aimed at enhancing employee capabilities and supporting career progression.
The Company also prioritises employee well-being, workplace safety and operational efficiency as key pillars of its human capital strategy. Initiatives such as process optimisation, adoption of digital technologies and promotion of a Zero Incident Culture reflect its commitment to creating a safe and efficient working environment. Through these efforts, the Company aims to build a capable workforce that supports product innovation, maintains high standards of quality and compliance and contributes to long-term organisational objectives.
1126 Total employees as of 31st March, 2026
India Pesticides Limited operates in a dynamic and evolving business environment and is exposed to various internal and external risks, including fluctuations in raw material prices, global supply chain disruptions, regulatory changes and shifting market conditions. These risks have the potential to impact cost structures, supply continuity and demand visibility. The Company has established a structured risk management framework to identify, assess, mitigate and monitor such risks, ensuring continuity and stability in its business processes. It undertakes systematic evaluation of risk factors, supported by probability and impact analysis, to enable timely implementation of mitigation measures.
The Companys risk management policy provides a comprehensive approach across all levels of the organisation and oversight at both the Committee of Directors and executive management levels. Through continuous monitoring and periodic reviews, the framework ensures that risks are effectively evaluated and mitigation strategies remain aligned with business requirements. The Companys focus on operational discipline, process optimisation and cost efficiency further supports its ability to manage risks and maintain resilience, enabling informed decision-making and sustained performance.
| External Risk Factors | IPL Comprehends | Mitigating Measures |
| Economic Environment and Market Conditions | Risks arising from economic slowdowns or abrupt changes in market conditions may impact demand and lead to revenue volatility. | The Company engages closely with customers, suppliers and channel partners to assess market trends. It undertakes periodic reviews of product mix, inventory and working capital while optimising resource utilisation. |
| Demand Fluctuations and Market Conditions | Variability in demand across domestic and export markets, influenced by agricultural cycles and recovery trends in global markets, may impact revenue visibility. | Maintaining a balanced presence across domestic and international markets and aligning its production and sales strategies with evolving demand patterns. |
| Political Environment | Political risks include potential disruptions arising from policy changes, geopolitical developments or regulatory actions across operating regions. | Relevant teams monitor political and regulatory developments across markets, enabling timely operational adjustments to ensure continuity and compliance. |
| Competition | Competitive pressures may impact pricing, margins and market share across product categories. | The Company focuses on diversifying its product portfolio, improving process efficiencies and strengthening its presence in regulated markets to sustain competitiveness. |
| Revenue Concentration and Liquidity Aspects | Dependence on key customers may expose the Company to revenue concentration risk, along with associated liquidity risks including short-term cash flow and long-term funding requirements. | The Company maintains long-term customer relationships while progressively diversifying its customer base. Internal strategies support better product mix decisions and customer expansion. |
| Inflation and Cost Structure / Raw Material Price Volatility | Inflationary pressures and fluctuations in raw material prices may impact input costs, margins and project cost structures. | Focusing on cost optimisation, process efficiency and prudent procurement strategies. Contractual arrangements and periodic reviews help manage cost escalations effectively. |
| Global Supply Chain Disruptions | Disruptions in global supply chains may affect availability of raw materials and impact production schedules. | The Company adopts diversified sourcing strategies and maintains operational flexibility to ensure continuity of operations. |
| Technology Obsolescence | Rapid technological advancements may impact competitiveness if processes or product offerings become outdated. | Evaluates market trends regularly and investing in process improvements and technology upgrades to remain aligned with industry developments. |
| Legal and Compliance | Non-compliance with applicable laws and regulations may result in legal and reputational risks. | The Company follows established compliance frameworks and integrates regulatory considerations into operational decision-making. |
| Fluctuations in Foreign Exchange | Variations in foreign exchange rates may impact profitability, particularly in export-oriented operations. | The Company follows a prudent approach to foreign exchange management, supported by periodic monitoring and policy-driven controls. |
All identified Internal Business Risk Factors are studied and reviewed quarterly/half yearly and annually by the Risk Management Committee of Executives. Measures are shared with Risk Management Committee for approval and implementation.
The Company remains focused on strengthening its position in the agrochemical sector through capacity expansion, backward integration and continued product development. Ongoing investments at existing facilities, along with the phased expansion of Shalvis Specialities Limited, are expected to enhance technical manufacturing capabilities and support future scale-up opportunities. The Company is also progressing with new technical and formulation capacities, while expanding intermediate manufacturing to improve supply assurance and cost competitiveness.
IPL continues to emphasise operational discipline, process optimisation and product innovation to improve efficiencies and strengthen margins. The Company is witnessing improving demand recovery across key export markets and is actively engaging with global customers across geographies including Japan, the United States and Australia for new business opportunities. Supported by increasing capacity utilisation, focus on CRDMO opportunities, renewable energy integration and a differentiated product portfolio, the Company remains focused on achieving sustainable long-term growth across domestic and international markets.
The Company maintains an internal financial control framework that is commensurate with the nature, scale and complexity of its operations. These controls are designed to ensure the orderly conduct of business and the accurate preparation and presentation of financial statements. The internal audit function is carried out by an independent external agency, which regularly reports its findings to the Audit Committee. This process provides the Board with assurance regarding the effectiveness of financial control systems. The internal audit mechanism also involves continuous monitoring and periodic evaluation of operations to ensure that control processes remain robust and effective.
The Management Discussion and Analysis (MD&A) section may include forward-looking statements related to the Companys objectives, plans, estimates and expectations, as per securities laws and regulations. It should be noted that the actual results may significantly vary from those suggested or inferred in these claims. Economic conditions, price fluctuations in domestic and international markets, competitive pressures, government regulations, tax laws, and other incidental factors can all have an impact on the Companys outcomes.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.